Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure–activity relationship studies

Bioorganic & Medicinal Chemistry
2009.0

Abstract

A series of 4-quinolylhydrazones was synthesized and tested in vitro against Mycobacterium tuberculosis. At a concentration of 6.25microg/mL, most of the newly synthesized compounds displayed 100% inhibitory activity against M. tuberculosis in cellular assays. Further screening allowed the identification of very potent antitubercular agents. Compound 4c was also tested in a time-course experiment and against mtb clinical isolates, displaying interesting results.

Knowledge Graph

Similar Paper

Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure–activity relationship studies
Bioorganic & Medicinal Chemistry 2009.0
Synthesis and antitubercular activity of 7-chloro-4-quinolinylhydrazones derivatives
Bioorganic & Medicinal Chemistry Letters 2009.0
Synthesis and antitubercular activity of novel pyrazole–quinazolinone hybrid analogs
Medicinal Chemistry Research 2013.0
Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea
Bioorganic & Medicinal Chemistry Letters 2006.0
Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents
Bioorganic & Medicinal Chemistry Letters 2010.0
Anti-tubercular activity of novel 4-anilinoquinolines and 4-anilinoquinazolines
Bioorganic & Medicinal Chemistry Letters 2019.0
Quinolone-isoniazid hybrids: synthesis and preliminary in vitro cytotoxicity and anti-tuberculosis evaluation
MedChemComm 2019.0
Design, synthesis, and evaluation of new 2-(quinoline-4-yloxy)acetamide-based antituberculosis agents
European Journal of Medicinal Chemistry 2020.0
7-chloro-3-(substituted benzylidene/phenyl ethylidene amino)-2-phenylquinazolin-4(3H)-ones: synthesis, antimicrobial and antitubercular evaluation
Medicinal Chemistry Research 2012.0
Antimycobacterial activity of novel hydrazide-hydrazone derivatives with 2 H -chromene and coumarin scaffold
Bioorganic & Medicinal Chemistry Letters 2017.0